InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,568.39
(
1.15%
)
US TECH 100
19,303.80
(
1.55%
)
Dow Jones
40,444.80
(
0.39%
)
Brent Oil
81.60
(
-0.83%
)
Bitcoin
67,938.40
(
-0.32%
)
Post# of 326
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Frankestin

Send PM Follow Ignore
Followers 8
Posts 1923
Boards Moderated 0
Alias Born 09/10/2012

Frankestin

Re: Frankestin post# 177

Friday, 12/17/2021 2:07:00 AM

Friday, December 17, 2021 2:07:00 AM

Post# of 326
it's not over
Next in Q4:
Phase 3 Endometriosis results.

Ebopiprant for treatment of preterm labor: Phase 2b dose ranging study initiation in EU/Asia (Q4:21)
Company plans to discuss with European regulators a possible accelerated registration program based on a Phase 2b/3 adaptive design.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent OBSV News
More OBSV News
InvestorsHub NewsWire

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!